Document is current
Any future updates will be listed below
-
Authors
Yabut, Julian M. https://orcid.org/0009-0001-3318-2854
Drucker, Daniel J. https://orcid.org/0000-0001-6688-8127
- License Information
-
More Information
Article History
Received: 21 January 2025
Accepted: 9 December 2025
First Online: 16 January 2026
Competing interests
: J.M.Y. has no competing interests or conflict of interest. D.J.D. has served as a consultant or speaker within the past 12 months to Alnylam, Amgen, AstraZeneca, Crinetics, Eli Lilly, General Medicines Inc., Kallyope, Metsera, Novo Nordisk, Pfizer Protagonist Therapeutivs Inc and Sanofi. Neither D.J.D. nor his family members hold issued stock directly or indirectly in any of these companies. D.J.D. holds nonexercised options in Kallyope. Mt. Sinai Hospital receives grant support from Amgen, Eli Lilly and Zealand Pharma for preclinical studies in the laboratory of D.J.D.
